Please login to the form below

Not currently logged in

Vir Biotechnology

This page shows the latest Vir Biotechnology news and features for those working in and with pharma, biotech and healthcare.

MHRA approves second COVID-19 antibody treatment

MHRA approves second COVID-19 antibody treatment

Developed by GSK and Vir Biotechnology, sotrovimab is a single monoclonal antibody that binds to the spike protein of the virus preventing it from replicating in the body. ... Sotrovimab was deliberately designed with a mutating virus in mind,” said

Latest news

More from news
Approximately 8 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Decibel Therapeutics expands leadership team Decibel Therapeutics expands leadership team

    Finally, Dr Scangos (pictured below left) has recently become chief executive officer of viral and bacterial diseases specialist Vir Biotechnology, having previously served as chief executive officer of Biogen from 2010 ... Prior to this, he was

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation